BackGlobal Blood Therapeutics Overview
Global Blood Therapeutics Inc.

Global Blood Therapeutics Discounted Cash Flow

DCF Analysis for GBT.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$79.37

Current Fair Value

$79.37
15.9% Upside

Undervalued by 15.9% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading